AMPE - Ampio Pharmaceuticals Inc. (AMPE) CEO on Q3 2020 Earnings Results - Conference Call Transcript

Ampio Pharmaceuticals, Inc. (AMPE) Q3 2020 Earnings Conference Call November 5, 2020 4:30 PM ET Participants Joe Hassett - Investor Relations, Gregory FCA Michael Macaluso - Founder, Chairman and Chief Executive Officer Dan Stokely - Chief Financial Officer Laura Goldberg - Vice President, Quality David Bar-Or - Director and Founder Presentation Operator Thank you and welcome to Ampio Pharmaceuticals Business Update and Financial Review Webinar. As a reminder, this call is being recorded, and all listeners will be in listen-only mode. [Operator Instructions] At this time, I would like to turn the call over to Mr. Joe Hassett. Joe, please go ahead. Joe Hassett Thanks, Reline and good afternoon, everybody. Ampio's statements in this conference call that are not historical facts and that relate to future plans or events are forward-looking statements within the meaning of the Private Securities Litigation Reform Act Of 1995. Forward-looking statements can be identified by

For further details see:

Ampio Pharmaceuticals, Inc. (AMPE) CEO on Q3 2020 Earnings Results - Conference Call Transcript